Skip to Content

IL 3625 (Theophylline Extended-Release 300 mg)

Pill with imprint IL 3625 is White / Clear, Capsule-shape and has been identified as Theophylline Extended-Release 300 mg. It is supplied by Inwood Laboratories Inc..

Theophylline is used in the treatment of asthma, maintenance; apnea of prematurity; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IL 3625

Theophylline Extended-Release

Imprint
IL 3625
Strength
300 mg
Color
White / Clear
Size
17.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Methylxanthines
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Inwood Laboratories Inc.
National Drug Code (NDC)
00258-3625

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.